Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments.
Zamanian MY, Soltani A, Khodarahmi Z, Alameri AA, Alwan AMR, Ramírez-Coronel AA, Obaid RF, Abosaooda M, Heidari M, Golmohammadi M, Anoush M. Zamanian MY, et al. Among authors: heidari m. Fundam Clin Pharmacol. 2023 Dec;37(6):1050-1064. doi: 10.1111/fcp.12926. Epub 2023 Jun 16. Fundam Clin Pharmacol. 2023. PMID: 37259891 Review.
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Zamanian MY, Parra RMR, Soltani A, Kujawska M, Mustafa YF, Raheem G, Al-Awsi L, Lafta HA, Taheri N, Heidari M, Golmohammadi M, Bazmandegan G. Zamanian MY, et al. Among authors: heidari m. Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155008 Review.
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings.
Zamanian MY, Terefe EM, Taheri N, Kujawska M, Tork YJ, Abdelbasset WK, Shoukat S, Opulencia MJC, Heidari M, Alesaeidi S. Zamanian MY, et al. Among authors: heidari m. CNS Neurol Disord Drug Targets. 2023;22(10):1453-1461. doi: 10.2174/1871527322666221005122408. CNS Neurol Disord Drug Targets. 2023. PMID: 36200161 Review.
816 results